Department of Health
and Human Services (HHS)
and Human Services (HHS)
May 4, 2021
RFA-AI-20-077 - Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Environmental Health Sciences (NIEHS)
This Notice is to alert potential applicants of a change to the Key Dates for RFA-AI-20-077, Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed).
The following changes (noted in italics) have been made:
Currently reads:
Part 1. Overview Information
Key Dates
Posted Date
January 12, 2021
Open Date (Earliest Submission Date)
May 04, 2021
Letter of Intent Due Date(s)
30 days before application due date
Application Due Date(s)
June 4, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
June 4, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
October 2021
Advisory Council Review
January 2022
Earliest Start Date
March 2022
Expiration Date
June 05, 2021
Due Dates for E.O. 12372
Not Applicable
Revised to read:
Part 1. Overview Information
Key Dates
Posted Date
January 12, 2021
Open Date (Earliest Submission Date)
May 18, 2021
Letter of Intent Due Date(s)
30 days before application due date
Application Due Date(s)
June 18, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS application sallowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
June 18, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
October 2021
Advisory Council Review
January 2022
Earliest Start Date
March 2022
Expiration Date
June 19, 2021
Due Dates for E.O. 12372
Not Applicable
All other aspects of this FOA remain unchanged.
Mercy Prabhudas, Ph.D., M.B.A.
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3534
Email: [email protected]
Que Dang, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-6181
Email: [email protected]
Anjali Singh, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3030
Email: [email protected]
Michael C. Humble, Ph.D.
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3272
Email: [email protected]